{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:39:49Z","timestamp":1790548789777,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.berh.2025.102039","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T07:40:39Z","timestamp":1738741239000},"page":"102039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Musculoskeletal manifestations in leprosy"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3073-2929","authenticated-orcid":false,"given":"Vitor Alves","family":"Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Carolina Faria Moreira Gomes","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a","family":"Monteiro de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Stella Cochrane","family":"Feitosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana Starling de","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro Martins","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane Angelina de","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licia Maria Henrique da","family":"Mota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.berh.2025.102039_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.47276\/lr.84.1.65","article-title":"Clinical characteristics and outcome in multibacillary (MB) leprosy patients treated with 12 months WHO MDT-MBR: a retrospective analysis of 730 patients from a leprosy clinic at a tertiary care hospital of Northern India","volume":"84","author":"Dogra","year":"2013","journal-title":"Lepr Rev"},{"issue":"1","key":"10.1016\/j.berh.2025.102039_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaad.2019.10.138","article-title":"Leprosy: treatment and management of complications","volume":"83","author":"Maymone","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.berh.2025.102039_bib3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1590\/S0365-05962008000400010","article-title":"Imunologia da hansen\u00edase","volume":"83","author":"Mendon\u00e7a","year":"2008","journal-title":"An Bras Dermatol"},{"issue":"4","key":"10.1016\/j.berh.2025.102039_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.PoH-0009-2015","article-title":"Paleomicrobiology of leprosy","volume":"4","author":"Spigelman","year":"2016","journal-title":"Microbiol Spectr"},{"issue":"5","key":"10.1016\/j.berh.2025.102039_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005669","article-title":"Ancient skeletal evidence for leprosy in India (2000 B.C.)","volume":"4","author":"Robbins","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.berh.2025.102039_bib6","unstructured":"WORLD HEALTH ORGANIZATION. Global leprosy (Hansen disease) update, 2023: moving towards interruption of transmission. Available in: https:\/\/www.who.int\/publications\/i\/item\/whower9736-429-450.."},{"issue":"1","key":"10.1016\/j.berh.2025.102039_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12915-021-01120-2","article-title":"Mycobacterium leprae diversity and population dynamics in medieval Europe from novel ancient genomes","volume":"19","author":"Pfrengle","year":"2021","journal-title":"BMC Biol"},{"key":"10.1016\/j.berh.2025.102039_bib8","article-title":"Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Doen\u00e7as de Condi\u00e7\u00f5es Cr\u00f4nicas e Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis","year":"2023","journal-title":"Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas da Hansen\u00edase"},{"issue":"1","key":"10.1016\/j.berh.2025.102039_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/ijd.IJD_80_17","article-title":"Clinical and histopathological response to multidrug therapy in paucibacillary leprosy at the end of 6 Months: a prospective observational study from eastern India","volume":"63","author":"Podder","year":"2018","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.berh.2025.102039_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1239775","article-title":"New insights at the interface between leprosy and immune-mediated rheumatic diseases","volume":"10","author":"Cruz","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.berh.2025.102039_bib11","unstructured":"HEALTH RESOURCES AND SERVICES ADMINISTRATION. National Hansen's Disease (Leprosy) Program: caring and curing since 1894. Available in: http:\/\/www.hrsa.gov\/hansensdisease\/. Acesso em: 20 June. 2011.."},{"key":"10.1016\/j.berh.2025.102039_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.879527","article-title":"Case report: a case series of immunobiological therapy (Anti-TNF-\u03b1) for patients with erythema nodosum leprosum","volume":"9","author":"Mendes","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.berh.2025.102039_bib13","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0336-2021","article-title":"Dramatic secukinumab-mediated improvements in refractory leprosy-related neuritis via the modulation of T helper 1 (Th1) and T helper 17 (Th17) immune pathways","volume":"54","author":"Kurizky","year":"2021","journal-title":"Rev Soc Bras Med Trop"},{"issue":"1","key":"10.1016\/j.berh.2025.102039_bib14","first-page":"111","article-title":"Articular inflammatory manifestations in patients with different forms of leprosy","volume":"25","author":"Cossermelli-Messina","year":"1998","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.berh.2025.102039_bib15","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s10067-013-2276-5","article-title":"Leprosy in a rheumatology setting: a challenging mimic to expose","volume":"32","author":"Salvi","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2025.102039_bib16","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/rheumatology\/keq264","article-title":"Arthritis in leprosy","volume":"49","author":"Chauhan","year":"2010","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2025.102039_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10067-008-0986-x","article-title":"Leprosy-related joint involvement","volume":"28","author":"Pereira","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2025.102039_bib18","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s10067-022-06090-6","article-title":"Neglected tropical rheumatic diseases","volume":"41","author":"Sahoo","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2025.102039_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2022.e01386","article-title":"Type 2 leprosy reaction presenting as a monoarthritis post multidrug therapy","volume":"27","author":"Goulart","year":"2022","journal-title":"IDCases"},{"issue":"4","key":"10.1016\/j.berh.2025.102039_bib20","first-page":"247","article-title":"Acute joint manifestations in leprosyl","volume":"17","author":"Modi","year":"1969","journal-title":"J Assoc Phys India"},{"key":"10.1016\/j.berh.2025.102039_bib21","first-page":"275","article-title":"Leprosy presenting as rheumatoid arthritis","volume":"13","author":"Lele","year":"1965","journal-title":"J Assoc Phys India"},{"issue":"6685","key":"10.1016\/j.berh.2025.102039_bib22","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.298.6685.1423","article-title":"Clinical and laboratory studies of arthritis in leprosy","volume":"298","author":"Atkin","year":"1989","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.berh.2025.102039_bib23","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4269\/ajtmh.19-0616","article-title":"Biologics in leprosy: a systematic review and case report","volume":"102","author":"Cogen","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.berh.2025.102039_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101670","article-title":"Use of methotrexate for leprosy reactions. Experience of a referral center and systematic review of the literature","volume":"37","author":"Perez-Molina","year":"2020","journal-title":"Trav Med Infect Dis"},{"issue":"3","key":"10.1016\/j.berh.2025.102039_bib25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4103\/0019-5154.43205","article-title":"Management of erythema nodosum leprosum by mycophenolate mofetil","volume":"53","author":"Banerjee","year":"2008","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.berh.2025.102039_bib26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3889\/oamjms.2021.7629","article-title":"Leprosy mimicking as rheumatoid arthritis: a case report","volume":"9","author":"Sridana","year":"2021","journal-title":"Open Access Maced J Med Sci"},{"issue":"4","key":"10.1016\/j.berh.2025.102039_bib27","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/rheumatology\/kel367","article-title":"Arthritis as presenting manifestation of pure neuritic leprosy \u2013 a rheumatologist's dilemma","volume":"46","author":"Haroon","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2025.102039_bib28","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/1756-185X.12668","article-title":"Evaluation of rheumatoid factor and anti-citrullinated peptide antibodies in relation to rheumatological manifestations in patients with leprosy from southern Brazil","volume":"19","author":"Dionello","year":"2016","journal-title":"Int J Rheum Dis"},{"issue":"10","key":"10.1016\/j.berh.2025.102039_bib29","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s10067-013-2276-5","article-title":"Leprosy in a rheumatology setting: a challenging mimic to expose","volume":"32","author":"Salvi","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2025.102039_bib30","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jhsa.2018.07.007","article-title":"Lessons from leprosy: peripheral neuropathies and deformities in chronic demyelinating diseases","volume":"44","author":"Chan","year":"2019","journal-title":"J Hand Surg Am"},{"key":"10.1016\/j.berh.2025.102039_bib31","article-title":"An overview of Charcot's neuroarthropathy","volume":"22","author":"Dardari","year":"2020","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.berh.2025.102039_bib32","doi-asserted-by":"crossref","DOI":"10.3402\/dfa.v4i0.21117","article-title":"An overview of the Charcot foot pathophysiology","volume":"4","author":"Kaynak","year":"2013","journal-title":"Diabet Foot Ankle"},{"issue":"1","key":"10.1016\/j.berh.2025.102039_bib33","first-page":"13","article-title":"Deformities and bony changes in leprosy","volume":"25","author":"Kumar","year":"2014","journal-title":"IJPMR"},{"issue":"2","key":"10.1016\/j.berh.2025.102039_bib34","first-page":"83","article-title":"Clinico-radiological correlation of bone changes in leprosy patients presenting with disabilities\/deformities","volume":"88","author":"Mohammad","year":"2016","journal-title":"Indian J Lepr"},{"issue":"3","key":"10.1016\/j.berh.2025.102039_bib35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/1534734609345142","article-title":"The potential role of magnetic resonance imaging in patients with Hansen's neuropathy of the feet: a preliminary communication","volume":"8","author":"Slim","year":"2009","journal-title":"Int J Low Extrem Wounds"},{"issue":"2","key":"10.1016\/j.berh.2025.102039_bib36","first-page":"83","article-title":"Clinico-radiological correlation of bone changes in leprosy patients presenting with disabilities\/deformities","volume":"88","author":"Mohammad","year":"2016","journal-title":"Indian J Lepr"},{"issue":"3","key":"10.1016\/j.berh.2025.102039_bib37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/1534734609345142","article-title":"The potential role of magnetic resonance imaging in patients with Hansen's neuropathy of the feet: a preliminary communication","volume":"8","author":"Slim","year":"2009","journal-title":"Int J Low Extrem Wounds"},{"issue":"3","key":"10.1016\/j.berh.2025.102039_bib38","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.fcl.2022.05.002","article-title":"Nonoperative treatment of Charcot neuro-osteoarthropathy","volume":"27","author":"Waibel","year":"2022","journal-title":"Foot Ankle Clin"},{"key":"10.1016\/j.berh.2025.102039_bib39","doi-asserted-by":"crossref","DOI":"10.1007\/s00402-021-03881-5","article-title":"Long-term follow-up of conservative treatment of Charcot feet","author":"Gratwohl","year":"2021","journal-title":"Arch Orthop Trauma Surg"},{"issue":"4","key":"10.1016\/j.berh.2025.102039_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011238","article-title":"Methotrexate as a corticosteroid-sparing agent in leprosy reactions: a French multicenter retrospective study","volume":"17","author":"Jaume","year":"2023","journal-title":"PLoS Neglected Trop Dis"},{"issue":"1","key":"10.1016\/j.berh.2025.102039_bib41","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1086\/518699","article-title":"Methotrexate treatment for type 1 (reversal) leprosy reactions","volume":"45","author":"Biosca","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.berh.2025.102039_bib42","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.trstmh.2006.11.010","article-title":"Response to ciclosporin treatment in Ethiopian and Nepali patients with severe leprosy Type 1 reactions","volume":"101","author":"Marlowe","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.berh.2025.102039_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004502","article-title":"A randomized controlled double blind trial of ciclosporin versus prednisolone in the management of leprosy patients with new type 1 reaction, in Ethiopia","volume":"10","author":"Lambert","year":"2016","journal-title":"PLoS Neglected Trop Dis"},{"issue":"1","key":"10.1016\/j.berh.2025.102039_bib44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000517993","article-title":"Cyclosporin A as an alternative neuroimmune strategy to control neurites and recover neuronal tissues in leprosy","volume":"29","author":"Jesus","year":"2022","journal-title":"Neuroimmunomodulation"},{"issue":"5","key":"10.1016\/j.berh.2025.102039_bib45","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1093\/cid\/ciq213","article-title":"Severe refractory erythema nodosum leprosum successfully treated with the tumor necrosis factor inhibitor etanercept","volume":"52","author":"Ramien","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.berh.2025.102039_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.879527","article-title":"Case report: a case series of immunobiological therapy (Anti-TNF-\u03b1) for patients with erythema nodosum leprosum","volume":"9","author":"Mendes","year":"2022","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.berh.2025.102039_bib47","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1111\/jdv.16764","article-title":"The risk of leprosy in patients using immunobiologics and conventional immunosuppressants for the treatment of dermatological and rheumatological diseases: a cohort study","volume":"35","author":"Martins Gomes","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694225000075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694225000075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:59:11Z","timestamp":1751381951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694225000075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1521694225000075"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2025.102039","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Musculoskeletal manifestations in leprosy","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2025.102039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102039"}}